Paul Martini Prize 2027
The Paul-Martini-Stiftung announces the annual Paul Martini Prize for the year 2027 and calls for entries. The Prize is endowed with EUR 50.000.
The award honours outstanding achievements in the clinical pharmacology. This includes the development and application of clinical-pharmacological methods for the assessment of therapeutic measures as well as therapy studies and their socio-economic aspects. During the selection, particular attention is paid to work that already contains results for application in humans. A German affiliation is required.
A jury of six renowned scientists, chaired by Prof. Dr. Robert Zeiser, Universitätsklinikum Freiburg, will determine the winner(s) of the Prize. The Prize was donated in commemoration of the eminent scientist and physician Professor Dr. Paul Martini (Bonn), to appreciate his contribution to the promotion and development of clinical therapeutic research. He has shaped this field over decades with his 'Methodology of Therapeutic Investigation', published in 1932.
The submitted papers (maximum of four) must be self-contained and either published within the current or the last two years or in press (with indication of journal). The submitting candidate must be the first author, second author with equal rights or senior author of the submitted work(s). The written consent of the non-submitting first author, second author of equal standing or senior author of the paper(s) must be enclosed. Applications from Paul Martini Prize winners of previous years cannot be considered.
In addition to the work(s) the application must include
Cover letter with contact and affiliation details, title of the application plus titles of up to four publications
Up to four publications to be submitted including a summary
Short Curriculum Vitae (with professional position, no photo)
List of publications of the last 5 years (applicant marked in bold)
The documents are to be sent as pdf to andrea.sydow@paul-martini-stiftung.de and m.meergans@vfa.de
Deadline of entry is Wednesday, December 9th, 2026.